ALKBH5 and colorectal carcinoma: Our study contributes novel insights into the anticancer roles of ALKBH5‐mediated m6A modification and suggests that targeting the ALKBH5‐mediated m6A modification of PHF20 mRNA can be a hopeful strategy for the intervention and treatment of CRC.